| Dr Beth Catherine Kliethermes, PHD | |
|
800 Hospital Drive, Green Team, Columbia, MO 65201 | |
| (573) 814-6000 | |
| Not Available |
| Full Name | Dr Beth Catherine Kliethermes |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 800 Hospital Drive, Columbia, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417601113 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 2021045118 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Beth Catherine Kliethermes, PHD 800 Hospital Drive, Green Team, Columbia, MO 65201 Ph: (573) 814-6000 | Dr Beth Catherine Kliethermes, PHD 800 Hospital Drive, Green Team, Columbia, MO 65201 Ph: (573) 814-6000 |
News Archive
Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent).
During a nationwide outbreak of healthcare-associated infections of an antibiotic-resistant bacteria, an Israeli hospital traced repeated infections of patients in its intensive care unit to an unexpected source-sink traps, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
The Medical College of Wisconsin has been awarded a five-year, $8 million, multi-investigator Program Project Grant (PPG) from the National Institutes of Health to understand how human pluripotent stem cells, defined as cells which if left to their own designs can develop into any of the more than 200 cell types in the human body, can be channeled to exclusively become heart muscle cells.
Baxter International Inc. announced today that it has submitted an application to the European Medicines Agency's Committee for Human Medicinal Products seeking marketing authorization for HyQ. HyQ is Baxter's investigational immunoglobulin (IG) therapy administered subcutaneously and facilitated by recombinant human hyaluronidase, a dispersion and permeation enhancer, for use in patients with primary immunodeficiencies.
In the first successful randomized trial of its kind, researchers have provided preliminary evidence that telephone-based smoking cessation counseling given to smokers shortly after undergoing lung cancer screening can be effective at helping people stop smoking.
› Verified 5 days ago
Kristin Dyer, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3400 | |
Dr. Randee Shenkel, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2804 Forum Blvd Ste 4, Columbia, MO 65203 Phone: 573-446-5034 Fax: 573-446-5046 | |
Jocelyn N Abanes, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Martha Brownlee-duffeck, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Adrionia Marie Molder, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 119 Parker Hall, Columbia, MO 65211 Phone: 573-882-2665 | |
Dr. Noel Marie Elrod, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 211 S 8th St, Columbia, MO 65211 Phone: 573-882-4677 Fax: 573-882-4583 | |
Ellen A Horwitz, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 402 N Keene St, Ste 101, Columbia, MO 65201 Phone: 573-882-6921 Fax: 573-882-1154 |